Velocity (Meridian) Clinical Research - Grand Island — Grand Island, Nebraska

Velocity (Meridian) Clinical Research - Grand Island is a clinical research site located in Grand Island, Nebraska, United States 68803.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Velocity (Meridian) Clinical Research - Grand Island has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: SARS-CoV2, COVID-19.

Sponsors: Vaxart.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity (Meridian) Clinical Research - Grand Island?

Velocity (Meridian) Clinical Research - Grand Island has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity (Meridian) Clinical Research - Grand Island conducted?

Velocity (Meridian) Clinical Research - Grand Island has 1 clinical trials on record, with 1 currently active. Their work covers SARS-CoV2, COVID-19.

Is Velocity (Meridian) Clinical Research - Grand Island accredited by Crixeo Health?

Velocity (Meridian) Clinical Research - Grand Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velocity (Meridian) Clinical Research - Grand Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.